All articles by Phillip Broadwith – Page 18
-
FeatureIt's even cheaper being green
Reducing the environmental impact of your lab can save money as well as water and fuel. Phillip Broadwith reports
-
Business
Generics triumph in anti-inflammatory patent battle
Pfizer settles deals to allow copycat celecoxib
-
Business
GSK corruption investigation widens
BBC investigation airs allegations of misconduct in Poland
-
Business
Baxter aims to divide and conquer
Firm will split off its biopharmaceuticals business from medical products
-
Business
Grangemouth will switch to shale gas feed by 2016, says Ineos
New terminal will take US ethane imports and outdated plants will shut down
-
Business
AstraZeneca boosts open innovation efforts
Web portal will make collaborative drug discovery easier
-
Business
$1.2bn J&J deceptive marketing fine overturned
Supreme court reverses decision to fine firm over Risperdal promotion
-
Business
US coal companies fined over water pollution
Comprehensive upgrades required to water treatment systems at mines and processing plants
-
Business
US focuses pharma supply chain scrutiny
Import pre-authorisation for trusted firms frees up resources to tackle purity problems
-
Business
UK to fast-track access to critical medicines
Patients could receive medicines before formal approval in exchange for monitoring data
-
Business
Bristol-Myers Squibb to close Irish plant
130 jobs to go at manufacturing site in Cruiserath
-
Business
Minerals Technologies wins tussle over Amcol
US firm outbids European rival Imerys for polymer and speciality minerals supplier
-
Business
Toray backs US shale gas boom
Japanese firm will invest £585m to build a new carbon fibre materials site
-
Business
Shell pulls out of chemicals in Australia
Energy giant will sell all downstream businesses to Vitol
-
BusinessRefined gels for cultured cells
Company profile: Biogelx makes self-assembled peptide hydrogels with tuneable properties
-
Business
Mitsui to close several Japanese plants and expand in China
Radical restructuring brings firm focus on speciality isocyanates
-
BusinessGenerics give injectables a shot
A rash of recent acquisitions sees generics companies eager to enter speciality manufacturing market